Lupin declines after USFDA concludes inspection with two observations at Ankleshwar facility

Lupin rises on getting USFDA approval for Famotidine injection

Mumbai, March 9 (Udaipur Kiran): Lupin is currently trading at Rs. 2288.50, down by 55.95 points or 2.39% from its previous closing of Rs. 2344.45 on the BSE. The scrip opened at Rs. 2297.40 and has touched a high and low of Rs. 2318.45 and Rs. 2283.00 respectively. So far 19622 shares were traded on … Read more

LPG Users Alert: Complete eKYC by August 16 Magic Photo Editor drops ₹12,579 before Pixel 11 launch! Jio’s Best Offer: Free WiFi for 1 Month, 100Mbps Internet!